PDCD1LG2 and neoplasm: Although PD-L2 can also inhibit T cell function, PD-1/PD-L1 blockers have received more attention because PD-L1 expression is higher in tumor cells than PD-L2, that is, in many human tumors, the high expression of PD-L1 leads to poor prognosis [19–22].